JPRN-UMIN000005202
Recruiting
未知
The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetes - The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetes
Department of Diabetes and Endocrinology, Kanto Rosai Hospital0 sites20 target enrollmentMarch 8, 2011
Conditionstype 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- type 2 diabetes
- Sponsor
- Department of Diabetes and Endocrinology, Kanto Rosai Hospital
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1, Subjects who have already been treated with oral hypoglycemic agents. 2, Subjects who are hypersensitive to this medicine and/or contaminants of this medicine. 3, Any condition that the investigator considers a potential obstacle to trial participation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Investigation of a switch from Insulin Therapy to a metformin & saxagliptin combination in patients with type 2 diabetes mellitusType 2 Diabetes mellitusMedDRA version: 12.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2009-016745-25-DEikfe GmbH
Completed
Not Applicable
Intensive versus conventional insulin therapy for inpatient medical patients [Insulinoterapia intensificada versus terapia habitual en pacientes hospitalizados por patología médica]HyperglycaemiaSigns and SymptomsElevated blood glucose levelISRCTN55845280ational Fund of Investigation and Development in Health (Fondo nacional de investigación y desarrollo en salud [FONIS]) (Chile)250
Recruiting
Not Applicable
A Step therapy by a premixed insulin therapies in poor control with type 2 diabetestype 2 diabetesJPRN-UMIN000008884yokohama city university school of medicine endcrinology and metabolism40
Unknown
Phase 4
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT01206647ikfe-CRO GmbH120
Recruiting
Not Applicable
Adequate adjustment from insulin degludec to insulin pump therapy in patient with type 1 diabetestype 1 diabetesJPRN-UMIN000013136Department of Pediatrics Osaka City University Graduate School of Medicine20